You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

e10030

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Von Hippel-Lindau Syndrome Trial run by the NEI (Ranibizumab, E10030)

Completed
Has Results
  • Von Hippel-Lindau Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 21, 2021

Age-Related Macular Degeneration Trial in Worldwide (E10030, bevacizumab or aflibercept, E10030 sham injection)

Terminated
Has Results
  • Age-Related Macular Degeneration
  • E10030
  • +2 more
  • Gilbert, Arizona
  • +206 more
Sep 29, 2020

Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)

Terminated
Has Results
  • Age-Related Macular Degeneration
  • E10030
  • +2 more
  • Tucson, Arizona
  • +120 more
Aug 13, 2018

Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)

Terminated
Has Results
  • Age-Related Macular Degeneration
  • E10030
  • +2 more
  • Phoenix, Arizona
  • +114 more
Aug 8, 2018

Age-Related Macular Degeneration Trial in New York (E10030)

Completed
  • Age-Related Macular Degeneration
  • E10030
  • New York, New York
    Denise Teuber
Jan 21, 2010